EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Aryl hydrocarbon receptor sulfenylation promotes glycogenolysis and rescues cancer chemoresistance

Nannan Zhou, Jie Chen, Zheng Ling, Chaoqi Zhang, Yabo Zhou, Dianheng Wang, Li Zhou, Zhenfeng Wang, Nan Sun, Xin Wang, Huafeng Zhang, Ke Tang und 3 weitere

Journal of Clinical Investigation · 15.12.2023 · 133 (24)

DOI: 10.1172/jci170753 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 15.12.2023. Verfasst von Nannan Zhou und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology and National Key Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences. Hauptthemen laut MEDLINE: Glycogenolysis, Neoplasms. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlycogenolysisNeoplasmsHumansReactive Oxygen SpeciesDrug Resistance, NeoplasmReceptors, Aryl Hydrocarbon

Stichwörter der Autor:innen

CancerCell BiologyCell stressMetabolismToxins/drugs/xenobiotics

Substanzen

Reactive Oxygen SpeciesReceptors, Aryl Hydrocarbon

Autor:innen und Institutionen

  • Department of Immunology and National Key Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences.
  • Department of Thoracic Surgery, National Cancer Center/Cancer Hospital; and.
  • Department of Breast Surgical Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) & Peking Union Medical College, Beijing, China.
  • Department of Pathology.
  • Department of Biochemistry and Molecular Biology, and.
  • Department of Immunology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Zhou, N., Chen, J., Ling, Z., Zhang, C., Zhou, Y., Wang, D., Zhou, L., Wang, Z., Sun, N., Wang, X., Zhang, H., Tang, K., Ma, J., Lv, J., & Huang, B. (2023). Aryl hydrocarbon receptor sulfenylation promotes glycogenolysis and rescues cancer chemoresistance. Journal of Clinical Investigation, 133(24). https://doi.org/10.1172/jci170753

Vancouver

Zhou N, Chen J, Ling Z, Zhang C, Zhou Y, Wang D, et al. Aryl hydrocarbon receptor sulfenylation promotes glycogenolysis and rescues cancer chemoresistance. Journal of Clinical Investigation. 2023;133(24). doi:10.1172/jci170753

BibTeX
@article{Zhou2023,
  author = {Zhou, Nannan and Chen, Jie and Ling, Zheng and Zhang, Chaoqi and Zhou, Yabo and Wang, Dianheng and Zhou, Li and Wang, Zhenfeng and Sun, Nan and Wang, Xin and Zhang, Huafeng and Tang, Ke and Ma, Jingwei and Lv, Jiadi and Huang, Bo},
  title = {Aryl hydrocarbon receptor sulfenylation promotes glycogenolysis and rescues cancer chemoresistance},
  journal = {Journal of Clinical Investigation},
  year = {2023},
  volume = {133},
  number = {24},
  doi = {10.1172/jci170753}
}
Kostenlos starten →